Many elderly subjects are at increased risk of infectious and noninfectious
diseases due to an age-related decline in lymphoid cell activity (immunose
nescence). Noninvasive means of enhancing cellular immunity are therefore d
esirable in the elderly. Previous reports have suggested that dietary suppl
ementation could represent an effective means of enhancing the activity of
circulating natural killer (NK) cells in the elderly. In the present study,
we have conducted a pre-post intervention trial to determine the impact of
dietary supplementation with probiotic lactic acid bacteria (LAB) on perip
heral blood NK cell activity in healthy elderly subjects. Twenty-seven volu
nteers consumed low-fat/low-lactose milk supplemented with known immunostim
ulatory LAB strains (Lactobacillus rhamnosus HN001 or Bifidobacterium lacti
s HN019) for a period of 3 weeks. A dietary run-in of milk alone was shown
to have no significant effect on NK cells. Irt contrast, the proportion of
CD56-positive lymphocytes in peripheral circulation was higher following co
nsumption of either LAB strain, and ex vivo PBMC tumoricidal activity again
st K562 cells was also increased. Supplementation with HN001 or HN019 incre
ased tumoricidal activity by an average of 101 and 62%, respectively; these
increases were significantly correlated with age, with subjects older than
70 years experiencing significantly greater improvements than those under
70 years. These results demonstrate that dietary consumption of probiotic L
AB in a milk-based diet may offer benefit to elderly consumers to combat so
me of the deleterious effects of immunosenescence on cellular immunity.